Skip to main content
TipRanks
Go Ultimate75% OFF

Merdury Biopharmaceutical Corporation (6932) Cash flow

Merdury Biopharmaceutical Corporation Cash Flow

TW:6932's free cash flow for Q2 2026 was NT$-28.93M. For the 2026 fiscal year, TW:6932's free cash flow was decreased by NT$-6.79M and operating cash flow was NT$-22.14M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -50.84MNT$ -34.71MNT$ -42.15MNT$ -25.84MNT$ -4.78M
NT$ 44.08MNT$ 108.65MNT$ -194.44MNT$ -185.40MNT$ -8.02M
NT$ -8.21MNT$ -50.52MNT$ 248.93MNT$ 240.61MNT$ 15.28M
NT$ 53.17MNT$ 68.01MNT$ 44.29MNT$ 31.94MNT$ 2.56M
NT$ -58.14MNT$ -45.81MNT$ -55.72MNT$ -94.50MNT$ -12.29M

Currency in TWD

Merdury Biopharmaceutical Corporation Cash Flow

-300M-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing